|

GZR18 injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Gan & Lee Pharmaceuticals.2

Indications

  • Liver Disease1
  • Obesity & Overweight1
  • Weight Loss1
  • Overweight or Obesity1

Other2 trials

Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
Phase 3
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.